Clinical Trials · NCT03841058

Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Name: Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Active Not RecruitingPhase 2Abaloparatide

Phase: Phase 2
Recruitment status: Active Not Recruiting
Sponsor: Hospital for Special Surgery, New York
Enrollment: 96
Start date: Aug 2019
Locations: 1 site, United States
Primary endpoint: Difference in measure of fusion mass bridging from transverse process to transverse process

View Abaloparatide compound reference